Chronic hepatitis B: New potential therapeutic drugs target-Reference-Cited by-同舟云学术

Chronic hepatitis B: New potential therapeutic drugs target

Published:2022-01-25 Issue:1 Volume:11 Page:57-72
ISSN:2220-3249
Container-title:World Journal of Virology
language:
Short-container-title:WJV

Author:

Leowattana Wattana,Leowattana Tawithep

Publisher

Baishideng Publishing Group Inc.

Reference91 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

2. World Health Organization. Global hepatitis report, 2017. [cited 30 April 2021]. Available from: https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/

3. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B

4. Estimating hepatitis B virus cccDNA persistence in chronic infection†

5. HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models;Emerging Microbes & Infections;2024-08-08

2. N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H;Molecules;2024-06-20

3. The association between Clonorchis sinensis infection and hepatocellular carcinoma in an endemic area: a study in Guangxi, China;2024-06-07

4. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

5. First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection;Journal of Hepatology;2023-11